Institutional shares held 67,853
0 calls
0 puts
Total value of holdings $1K
$0 calls
$0 puts
Market Cap $259K
12,955,400 Shares Out.
Institutional ownership 0.52%
# of Institutions 3


Latest Institutional Activity in NMTR

Top Purchases

Q2 2024
Strategic Investment Solutions, Inc. /Il Shares Held: 5.5K ($110)
Q4 2022
Core Cap Advisors, LLC Shares Held: 101 ($2.02)
Q3 2022
Gsa Capital Partners LLP Shares Held: 2.35M ($47K)
Q3 2022
Renaissance Technologies LLC Shares Held: 1.66M ($33.2K)
Q3 2022
Vanguard Group Inc Shares Held: 12.6M ($251K)

Top Sells

Q3 2022
Curi Wealth Management, LLC Shares Held: 65.1K ($1.3K)
Q3 2022
Adage Capital Partners Gp, L.L.C. Shares Held: 13M ($260K)
Q3 2022
Millennium Management LLC Shares Held: 959K ($19.2K)
Q3 2022
Susquehanna International Group, LLP Shares Held: 28.6K ($572)
Q3 2022
Ergoteles LLC Shares Held: 911K ($18.2K)

About NMTR

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.


Insider Transactions at NMTR

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on NMTR

Follow 9 METERS BIOPHARMA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTR shares.

Notify only if

Insider Trading

Get notified when an 9 Meters Biopharma, Inc. insider buys or sells NMTR shares.

Notify only if

News

Receive news related to 9 METERS BIOPHARMA, INC.

Track Activities on NMTR